Elanco Animal Health, Inc. (ELAN)
19.97
+0.11
(+0.55%)
USD |
NYSE |
May 18, 10:51
Elanco Animal Health Research and Development Expense (Quarterly) : 97.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Zoetis, Inc. | 180.00M |
| Eli Lilly & Co. | 3.51B |
| Amneal Pharmaceuticals, Inc. | 38.38M |
| Arvinas, Inc. | 60.00M |
| Corcept Therapeutics, Inc. | 66.26M |